Cardiff Oncology
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRDF and other ETFs, options, and stocks.About CRDF
Cardiff Oncology, Inc. is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. The firm is focused on developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted therapeutics.
CRDF Key Statistics
Stock Snapshot
The current Cardiff Oncology(CRDF) stock price is $1.64, with a market capitalization of 110.75M. The stock trades at a price-to-earnings (P/E) ratio of -2.37.
On 2026-04-15, Cardiff Oncology(CRDF) stock traded between a low of $1.57 and a high of $1.67. Shares are currently priced at $1.64, which is +4.5% above the low and -1.5% below the high.
Cardiff Oncology(CRDF) shares are trading with a volume of 901.81K, against a daily average of 783.58K.
In the last year, Cardiff Oncology(CRDF) shares hit a 52-week high of $4.56 and a 52-week low of $1.48.
In the last year, Cardiff Oncology(CRDF) shares hit a 52-week high of $4.56 and a 52-week low of $1.48.
Analyst ratings
88%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.